Cargando…
Fibroblast growth factor 21 may be a strong biomarker for renal outcomes: a meta-analysis
BACKGROUND: Fibroblast growth factor 21 (FGF21) is deemed to play an important role in kidney outcomes, while the association between FGF21 and various kidney diseases remains largely unclear and inconsistent. Therefore, we conducted this meta-analysis to find out the role of FGF21 in various renal...
Autores principales: | Yong, Guo, Li, Ling, Hu, Shanbiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071947/ https://www.ncbi.nlm.nih.gov/pubmed/37009852 http://dx.doi.org/10.1080/0886022X.2023.2179336 |
Ejemplares similares
-
Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients
por: Fayed, Ahmed, et al.
Publicado: (2018) -
Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy
por: Zhang, Junlin, et al.
Publicado: (2018) -
Circulating Fibroblast Growth Factor 21 (Fgf21) as Diagnostic and Prognostic Biomarker in Renal Cancer
por: Knott, ME, et al.
Publicado: (2016) -
Circulating Galectin-3 levels and Diabetic Nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023) -
Correction to: Circulating galectin-3 levels and diabetic nephropathy: a systematic review and meta-analysis
por: Guo, Yong, et al.
Publicado: (2023)